CVE-2026-17270

CVE-2026-17270 is a medium-severity vulnerability in Ibm I with a CVSS 3.x base score of 4.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-121.

Key facts

Description

IBM i 7.6, 7.5, 7.4, and 7.3 could allow a local attacker to cause a denial of service due to a stack-based buffer overflow.

Frequently asked questions

What is CVE-2026-17270?
IBM i 7.6, 7.5, 7.4, and 7.3 could allow a local attacker to cause a denial of service due to a stack-based buffer overflow.
How severe is CVE-2026-17270?
CVE-2026-17270 has a CVSS 3.x base score of 4.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity none, and availability low.
Is CVE-2026-17270 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-17270?
CVE-2026-17270 primarily affects Ibm I. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2026-17270?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2026-17270 published?
CVE-2026-17270 was published on 2026-09-04 and last updated on 2026-09-10.

References

Affected products (4)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-121 (Stack-based Buffer Overflow) vulnerabilities

Browse all CWE-121 (Stack-based Buffer Overflow) vulnerabilities →